Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490412 · ClinicalTrials.gov registry record · NA
Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection
A NA study of HIV Infections, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 207
- Enrollment target
- 15
- Study locations
NCT00490412: Completed NA study of HIV Infections, sponsored by University of North Carolina, Chapel Hill.
NCT00490412 is a NA study of HIV Infections that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 207 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (53% lower). The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490412, a NA study of HIV Infections, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to test the effects of Vitamin D on renal phosphate and bone loss, which are common in HIV infected adolescents and young adults being treated with tenofovir.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D supplement
Study Locations (15)
Florida
- Children's Diagnostic and Treatment Center - Fort Lauderdale
- University of Miami - Miami
- University of South Florida - Tampa
California
- Children's Hopsital of Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
Illinois
- Stroger Hospital of Cook County - Chicago
- Childrens Memorial Hospital - Chicago
New York
- Mount Sinai Hospital - New York
- Montefiore Medical Center - The Bronx
District of Columbia
- Children's National Medical Center - Washington D.C.
Louisiana
- Tulane University - New Orleans
Maryland
- University of Maryland Medical School - Baltimore
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-01 |
| Phase | NA |
What the finished NCT00490412 record still lists
NCT00490412 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (53% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00490412 lists 15 locations in 10 states (Florida, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT00490412 about?
NCT00490412 is a clinical study titled "Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection". The purpose of this study is to test the effects of Vitamin D on renal phosphate and bone loss, which are common in HIV infected adolescents and young adults being treated with tenofovir.
What is the current status of trial NCT00490412?
This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2007-12. Estimated completion is 2010-01.
What conditions does trial NCT00490412 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00490412?
The interventions under investigation include: Placebo (OTHER), Vitamin D supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00490412?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00490412 being conducted?
This trial has 15 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00490412's enrollment target sits among peer trials
207 167th of 542 higher than 376 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia